Cures Acceleration Network: BIO Strongly Supports the CAN Program

On behalf of the Biotechnology Industry Organization (BIO), I am writing to express our strong support for $500 million for Cures Acceleration Network (CAN) Act, a new initiative at the National Industries of Health (NIH) that was authorized in the recently-enacted Patient Protections and Afforadable Care Act.